FDA OKs Symplicity Renal Denervation System for Hypertension FDA OKs Symplicity Renal Denervation System for Hypertension

After a mixed FDA panel review in August, the agency has approved Medtronic ' s Symplicity Spyral renal denervation system for treatment of hypertension.Medscape Medical News
Source: Medscape Pathology Headlines - Category: Pathology Tags: Cardiology News Alert Source Type: news